Preserved NSS at 2 and at 24 hours following ischemia and decreased infarct volume in PAR1 KO mice 24 hours following ischemic stroke. by Efrat Shavit-Stein (3186678)

“…(C) Total infarct volume is significantly lower in PAR1 KO mice compared to control (t-test, WT = 6, PAR1 KO = 6). (D) Infarct volume decreases as a function of distance from the ischemic core (slices #5&6). …”

A homozygous point mutation in the <i>Mrps34</i> gene causes a decrease in the MRPS34 protein. by Tara R. Richman (713532)

“…The 5′- and 3′-untranslated regions are shown as grey boxes and the predicted mitochondrial targeting sequence is shown as a black box (predicted using MitoProtII, [<a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1005089#pgen.1005089.ref040" target="_blank">40</a>]). …”

Fluoxetine decreases TOPFlash firefly luciferase reporter activity. by Kentaro Miyamoto (123271)

<i>Dmd^mdx</i> rats are characterized by muscle weakness and by a decrease in a spontaneous activity. by Thibaut Larcher (331981)

“…<i>Dmd^mdx</i> rats showed fatigue with a decreased force grip across the five pulls, and significant values are obtained for the two last trials that were reduced to ∼70% when compared to Trial 1. …”

Total RNAP II levels decrease during WT HSV-1 KOS infection. by Mark Ou (474248)

Resveratrol decreased intracellular levels of R5P. by Mohd Askandar Iqbal (324124)

“…<p>R5P is a pentose phosphate pathway intermediate, an important marker for anabolism (nucleotide biosynthesis). …”

Decreased Tks5 expression results in neural crest-derived defects. by Danielle A. Murphy (212554)

“…<p>(A–B) Melanophores within the trunk region above the yolk sac extension in control MO-injected and Tks5 MO-injected embryos were qualitatively (A) and quantitatively (B) analyzed. n = 15 embryos and SEM is shown by bar. p values obtained from Student's t-test. ** denotes p<0.01. …”

Nicotine decreased Wnt5a expressions in SK-BR-3 cells. by Masanori A. Murayama (5774585)

Pretreatment of β-cells with recombinant CXCL12 improves viability and induces a decrease in PARP-1 activity. by Nevena Grdović (394542)

PGC-1β KO mice show a specific decrease in Mfn2 expression in skeletal muscle. by Marc Liesa (35879)

Decrease of locomotor activity in <i>Auts2</i> mutant mice during habituation. by Kei Hori (840871)

“…Data are presented as the mean ± SEM (A: WT, n = 17, <i>Auts2</i>^<i>neo/+</i> = 14 and B: WT, n = 10, <i>Auts2</i>^<i>neo/+</i> = 9). …”

ATXN3 depletion decreases PNKP’s 3’-phosphatase activity. by Arpita Chatterjee (529752)

Prey establishment and decrease in inter-population contacts protects T6SS sensitive lineages. by Marta Rudzite (15991136)

“…Representative simulation outputs showing how decrease in initial bacterial density (<b>C</b>) or changes in strain mixing ratio (<b>E</b>) within initial population promotes prey (red) survival in a mix attacker population (green) with differing mean of T6SS firing rate and within a context of highly lytic toxins. …”

WT1 (+KTS) decreases basal and GnRH-stimulated LHβ promoter activity. by Debalina Bagchi (686046)

Fasting-induced decreases of lipogenic gene expression are unimpaired in Bcl6 KO mice. by Christopher R. LaPensee (571785)

“…Gene expression in fasted mice was calculated compared to fed mice, with fed state set to 1 for fed WT. Measurements are expressed as the mean+SE for n = fed: 9 WT, 5 KO, fasted: 5 WT, and 3 KO mice. …”

Behavioral response to ambiguous conditioned fear cues is decreased in adult neurogenesis-deficient mice. by Lucas R. Glover (3912628)

Het GIP Tg mice exhibited decreased physical activity but unaltered energy expenditure. by Su-Jin Kim (90561)

Muscle strength and total activity are decreased in <i>Htra2</i>-deficient mice. by Victoria L. Patterson (678436)

Down-regulation of <i>T. gondii</i> P-gp correlates with decreased lipid synthesis. by Iveta Bottova (250537)

Fenretinide decreases levels of PAX3/FOXO1 and its target genes in aRMS cell lines. by David Herrero Martín (286820)

“…<p>Rh4 and RMS13 cells were treated for 24 hours (A) and 48 hours (B) with different concentrations of fenretinide (0.5–1–5 µM, as indicated). …”